Access the Infographic: Unannounced FDA Inspections Without Borders

With unannounced inspections and public reporting of results beginning as early as August 2025, sponsors must ensure readiness for their external partners, or else risk undoing years of investment, planning and trust.

Explore the current compliance landscape, the impact of changes, and how to ensure Inspection Readiness with ProPharma, plus:

• How sponsors can prepare for upcoming inspection requirements
• Compliance trends, top citation hot-spots, and why even experienced facilities face challenges
• Understand what the FDA is looking for - consistency, control and credibility
• The ripple effect of non-readiness
• Avoid common setbacks
• Utilizing ProPharma’s decades of global regulatory expertise for routine real-time readiness